Katja Nickel, Katharina Schütz, Julia Carlens, Simon Grewendorf, Martin Wetzke, Oliver Keil, Nils Dennhardt, Vanessa Rigterink, Harald Köditz, Michael Sasse, Christine Happle, Christiane E Beck, Nicolaus Schwerk
{"title":"对小儿肺泡蛋白病进行全肺灌洗的十年经验","authors":"Katja Nickel, Katharina Schütz, Julia Carlens, Simon Grewendorf, Martin Wetzke, Oliver Keil, Nils Dennhardt, Vanessa Rigterink, Harald Köditz, Michael Sasse, Christine Happle, Christiane E Beck, Nicolaus Schwerk","doi":"10.1055/a-2194-3467","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pulmonary Alveolar Proteinosis (PAP) is extremely rare and can be caused by hereditary dysfunction of the granulocyte macrophage colony-stimulating factor receptor (GM-CSF) receptor, autoantibodies against GM-CSF, or other diseases leading to alveolar macrophage (AM) dysfunction. This leads to protein accumulation in the lung and severe dyspnea and hypoxemia. Whole lung lavage (WLL) is the first line treatment strategy.</p><p><strong>Methods: </strong>Here, we present data from more than ten years of WLL practice in pediatric PAP. WLL performed by the use of a single lumen or double lumen tube (SLT vs. DLT) were compared for technical features, procedure time, and adverse events.</p><p><strong>Results: </strong>A total of n=57 procedures in six PAP patients between 3.5 and 14.3 years of age were performed. SLT based WLL in smaller children was associated with comparable rates of adverse events but with longer intervention times and postprocedural intensive care treatment when compared to DLT based procedures.</p><p><strong>Discussion: </strong>Our data shows that WLL is feasible even in small children. DLT based WLL seems to be more effective, and our data supports the notion that it should be considered as early as possible in pediatric PAP.</p><p><strong>Conclusion: </strong>WLL lavage is possible in small PAP patients but should performed in close interdisciplinary cooperation and with age appropriate protocols.</p>","PeriodicalId":17846,"journal":{"name":"Klinische Padiatrie","volume":" ","pages":"64-72"},"PeriodicalIF":1.2000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10883753/pdf/","citationCount":"0","resultStr":"{\"title\":\"Ten-year experience of whole lung lavage in pediatric Pulmonary Alveolar Proteinosis.\",\"authors\":\"Katja Nickel, Katharina Schütz, Julia Carlens, Simon Grewendorf, Martin Wetzke, Oliver Keil, Nils Dennhardt, Vanessa Rigterink, Harald Köditz, Michael Sasse, Christine Happle, Christiane E Beck, Nicolaus Schwerk\",\"doi\":\"10.1055/a-2194-3467\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Pulmonary Alveolar Proteinosis (PAP) is extremely rare and can be caused by hereditary dysfunction of the granulocyte macrophage colony-stimulating factor receptor (GM-CSF) receptor, autoantibodies against GM-CSF, or other diseases leading to alveolar macrophage (AM) dysfunction. This leads to protein accumulation in the lung and severe dyspnea and hypoxemia. Whole lung lavage (WLL) is the first line treatment strategy.</p><p><strong>Methods: </strong>Here, we present data from more than ten years of WLL practice in pediatric PAP. WLL performed by the use of a single lumen or double lumen tube (SLT vs. DLT) were compared for technical features, procedure time, and adverse events.</p><p><strong>Results: </strong>A total of n=57 procedures in six PAP patients between 3.5 and 14.3 years of age were performed. SLT based WLL in smaller children was associated with comparable rates of adverse events but with longer intervention times and postprocedural intensive care treatment when compared to DLT based procedures.</p><p><strong>Discussion: </strong>Our data shows that WLL is feasible even in small children. DLT based WLL seems to be more effective, and our data supports the notion that it should be considered as early as possible in pediatric PAP.</p><p><strong>Conclusion: </strong>WLL lavage is possible in small PAP patients but should performed in close interdisciplinary cooperation and with age appropriate protocols.</p>\",\"PeriodicalId\":17846,\"journal\":{\"name\":\"Klinische Padiatrie\",\"volume\":\" \",\"pages\":\"64-72\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10883753/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinische Padiatrie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2194-3467\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinische Padiatrie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2194-3467","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/23 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
摘要
背景:肺泡蛋白沉积症(PAP)极为罕见,可由粒细胞巨噬细胞集落刺激因子受体(GM-CSF)受体的遗传性功能障碍、GM-CSF自身抗体或导致肺泡巨噬细胞(AM)功能障碍的其他疾病引起。这会导致蛋白质在肺部积聚,出现严重的呼吸困难和低氧血症。全肺灌洗(WLL)是一线治疗策略。方法:在此,我们介绍了十多年来在儿科 PAP 中进行全肺灌洗的数据。我们比较了使用单腔管或双腔管(SLT 与 DLT)进行全肺灌洗的技术特点、手术时间和不良事件:结果:共为 6 名年龄在 3.5 岁至 14.3 岁之间的 PAP 患者进行了 57 次手术。与基于 DLT 的手术相比,基于 SLT 的 WLL 在较小儿童中的不良事件发生率相当,但干预时间和术后重症监护治疗时间更长:讨论:我们的数据显示,WLL 即使在较小的儿童中也是可行的。基于 DLT 的 WLL 似乎更有效,我们的数据支持了应尽早考虑在小儿 PAP 中使用 WLL 的观点:结论:对小儿 PAP 患者进行 WLL 灌洗是可行的,但应在多学科密切合作下进行,并采用适合其年龄的方案。
Ten-year experience of whole lung lavage in pediatric Pulmonary Alveolar Proteinosis.
Background: Pulmonary Alveolar Proteinosis (PAP) is extremely rare and can be caused by hereditary dysfunction of the granulocyte macrophage colony-stimulating factor receptor (GM-CSF) receptor, autoantibodies against GM-CSF, or other diseases leading to alveolar macrophage (AM) dysfunction. This leads to protein accumulation in the lung and severe dyspnea and hypoxemia. Whole lung lavage (WLL) is the first line treatment strategy.
Methods: Here, we present data from more than ten years of WLL practice in pediatric PAP. WLL performed by the use of a single lumen or double lumen tube (SLT vs. DLT) were compared for technical features, procedure time, and adverse events.
Results: A total of n=57 procedures in six PAP patients between 3.5 and 14.3 years of age were performed. SLT based WLL in smaller children was associated with comparable rates of adverse events but with longer intervention times and postprocedural intensive care treatment when compared to DLT based procedures.
Discussion: Our data shows that WLL is feasible even in small children. DLT based WLL seems to be more effective, and our data supports the notion that it should be considered as early as possible in pediatric PAP.
Conclusion: WLL lavage is possible in small PAP patients but should performed in close interdisciplinary cooperation and with age appropriate protocols.
期刊介绍:
Das Forum für wissenschaftliche Information in der Kinderheilkunde
ausgewählte Originalarbeiten aus allen Bereichen der Pädiatrie
Visite: Ihr Forum für interessante Krankengeschichten und außergewöhnliche Kasuistiken
aktuelle Fortschritte in Diagnostik und Therapie
jährliche Schwerpunkthefte: Ergebnisse der pädiatrischen Onkologie
plus Medizin und Markt
topaktuelle Informationen aus der Industrie